US Patent 7595293 Stable pharmaceutical compositions
Patent 7595293 was granted and assigned to Novo Nordisk on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Claude Bonde0
Dorthe Kot Engelund0
Tina Bjeldskov Pedersen0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+152 characters)
Article
Patent abstract
Pharmaceutical composition for parenteral administration comprising a glucagon-like peptide and human serum albumin or a variant thereof.
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07595293 Stable pharmaceutical compositions US Patent 7595293 Stable pharmaceutical compositions
Infobox
Patent Number
075952930
Patent Number
75952930
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075952930
Date of Patent
September 29, 2009
0Patent Application Number
112444970
Date Filed
October 3, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07595293 Stable pharmaceutical compositions
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07595293
Date of patent
September 29, 2009
Patent application number
11244497
Date Filed
October 3, 2005
Patent primary examiner
Find more entities like US Patent 7595293 Stable pharmaceutical compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
